| 产品描述: | Ifetroban (BMS-180291) 是一种具有口服活性的血栓素 A2 (TXA2) 或前列腺素 H2 (PGH2) 受体拮抗剂。Ifetroban 具有抗血小板活性,可抑制肿瘤细胞迁移,但不影响细胞增殖。Ifetroban 可用于心肌缺血、高血压、中风、血栓、心肌病的研究。 |
| 靶点: |
TXA2/TP |
| 体外研究: |
Ifetroban (CPI211) (100 nM; 48 h) results Tpr inhibition and potently blocks spontaneous metastasis from primary tumors, without affecting tumor cell proliferation, motility, or tumor growth in 4T1 cells (mouse mammary cancer). Ifetroban (100 nM; 6 h) strongly inhibits PKC substrate phosphorylation, and blocks agonist (U46619)-induced TPr diminution in human umbilical vein endothelial cells (HUVECs). |
| 体内研究: |
Ifetroban (50 mg/kg/d; p.o.; 2 d prior to, through 28 d after tumor injection) decreases hematogenous metastasis of multiple cancer types without in mice model.
Ifetroban (50 mg/kg/d; p.o.; 12 d) does not affect primary tumor growth but decreases t 웿 Ů ñ 샮㡽䇘睜⪰ޏࠃ 䇩睜 䇩睜Ȃ Ӥ 晐睦Ӥ 晐睦Ӥ 峀睜 弴睜 ڤ 犐ƈ ڤ郥댻嬧睜Ӥ 乨Ƥ鄩댻婯睜Љ �ޝ乜Ƥ媜睜 Ӥ ItemҮ쎾番莰ଁ뢜సങ獲䥷唍హ ⻌హ�唒⸼హ ଁ 敖ﰨ 唎т |
| 保存条件: |
-20°C, 氮气保存 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.27 ml |
11.35 ml |
22.7 ml |
| 5 mM |
0.454 ml |
2.27 ml |
4.54 ml |
| 10 mM |
0.227 ml |
1.135 ml |
2.27 ml |
| 50 mM |
0.045 ml |
0.227 ml |
0.454 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |